Clinical trial
PET Scans in Patients With Locally Advanced Breast Cancer
NCT00109785 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00109785 |
|---|---|
| Title | PET Scans in Patients With Locally Advanced Breast Cancer |
| Official title | Positron Emitter I-124-Iododeoxyuridine to Follow DNA Metabolism on Scans and in Tumor Samples in Advanced Breast Cancer: Comparison to 18-F-2-Fluoro-2-Deoxy-(D)-Glucose, as a Tracer for Glycolysis |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | positron emission tomography, fludeoxyglucose F 18, iodine I 124 iododeoxyuridine |
| Enrollment | 8 |
| Start date | Mar 1, 1997 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 4, 2005 |
| Last update posted | Dec 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: